Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 18, 2024 08:30 ET | Source: Vaccinex, Inc.

Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds

ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...
August 29, 2023 06:15 ET | Source: Welsbach Technology Metals Acquisition Corp.

Welsbach Technology Metals Acquisition Corp. Announces Extension to Business Combination Deadline

New York, NY, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Welsbach Technology Metals Acquisition Corp. (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange,...
April 28, 2023 06:00 ET | Source: Welsbach Technology Metals Acquisition Corp.

Welsbach Technology Metals Acquisition Corp. Announces Extension to Business Combination Deadline

New York, NY, April 28, 2023 (GLOBE NEWSWIRE) -- Welsbach Technology Metals Acquisition Corp. (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange,...
May 26, 2020 07:30 ET | Source: ContraFect Corporation

ContraFect Corporation Announces Private Placement of Common Stock and Warrants to Pfizer Inc.

YONKERS, N.Y., May 26, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the...
December 07, 2018 18:11 ET | Source: Emerald Health Therapeutics Inc.

Emerald Health Therapeutics Closes $10.8 Million Prospectus Sale

VICTORIA, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald" or the “Company”) closed today its prospectus sale (the “Offering”)...